Delivery Order SPE2DB22D3102-SPE2DB24FK9CS
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,495.72 firm fixed-price delivery order is for the supply of 4562473934 ! METHYLERGONOVINE 0.2 MG TABLET 28S, with a completion date of October 16, 2023. The contract is not designated with a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award, valued at $9,531.97, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which runs through November 2026. The contract is for the supply of 4563743396 ! METHYLERGONOVINE 0.2 MG TABLET 28S, a pharmaceutical product. The award has a firm fixed price pricing...
- This federal contract award SPE2DB20D3103|SPE2DB25FN5Q0 was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $1,196.66, is for the delivery of 4568013187 METHYLERGONOVINE 0.2 MG/ML VLML. This is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,147.50 firm fixed-price delivery order is for the supply of METHYLERGONOVINE 0.2 MG/ML VLML, a pharmaceutical product. The contract has an ultimate completion date of September 30, 2022 and was awarded on September 29, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- The federal contract award SPE2DB20D7059|SPE2DB24FQJR0 was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of 4565157885 - METHYLERGONOVINE 0.2 MG/ML AMP/ML. The contract has a firm fixed price of $1,007.70 and a completion date of July 17, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of 4566370474 METHYLERGONOVINE 0.2 MG TABLET 12S, a pharmaceutical product, with a ceiling value of $2,109.54 and a completion date of November 8, 2024. The contract is a Delivery Order, with a Firm Fixed Price pricing type. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $1,196.64 delivery order contract is for the supply of 4565432737 ! METHYLERGONOVINE 0.2 MG/ML VLML, a pharmaceutical product. The contract has a firm fixed-price pricing structure and an ultimate completion date of August 14, 2024. This award is not associated with a set-aside program. Amerisourcebergen is a major supplier of pharmaceutical products...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,061.73, is for the delivery of 4565100038 ! METHYLERGONOVINE 0.2 MG TABLET 12S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of July 10, 2024. The contract is not designated as a set-aside...
- This federal contract award, valued at $3,146.73, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order for the supply of 4563095243 - METHYLERGONOVINE 0.2 MG TABLET 12S, with a performance period through December 14, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award, valued at $1,682.19, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,206,972 units of Methylergonovine 0.2 mg tablets by October 28, 2024. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract...
- SPE2DB22D3102Indefinite Delivery Contract
- SPE2DB22D3102-SPE2DB24FK9CSDelivery Order
This federal contract award, with an ID of SPE2DB22D3102|SPE2DB24FK9CS, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award is for the delivery of 4562970707 ! METHYLERGONOVINE 0.2 MG TABLET 28S, with an ultimate completion date of December 4, 2023 and a ceiling value of $1,988.64. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense and Department of Veterans Affairs healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 12/1/23 |